Delivery Order SPE2DB22D1106-SPE2DB24FFNF1
Award Date
9/25/24
Potential Completion Date
9/26/24
Potential Value
$1.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This delivery order contract, valued at $8,569.49, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp's Corporate Office Division. The contract is for the supply of GARDASIL 9 SYRINGE 0.5ML, a vaccine product. The contract has a completion date of September 23, 2024 and is structured as a firm fixed price arrangement. AmerisourceBergen, a major pharmaceutical distributor, has been awarded multiple federal contracts and Indefinite Delivery...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office division, a major pharmaceutical distributor. The $9,950.72 firm-fixed-price contract is for the supply of GARDASIL 9 SYRINGE 0.5ML, a vaccine product. The contract has an ultimate completion date of August 27, 2024 and is not a set-aside award. Amerisourcebergen is a large supplier of pharmaceuticals and medical supplies to various federal agencies and healthcare...
This is a delivery order awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $24,574.24 firm fixed price contract is for the supply of GARDASIL 9 vaccine syringes. The contract has an ultimate completion date of April 18, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025,...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,616.78 firm fixed price delivery order is for the supply of GARDASIL 9 SYRINGE 0.5ML, a vaccine product. The contract has an ultimate completion date of September 25, 2024 and is not designated as a set-aside. Amerisourcebergen, through its Corporate Office division, has been awarded numerous federal contracts and Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distribution company. The contract is for the supply of GARDASIL 9 SYRINGE 0.5ML, a vaccine product, at a ceiling value of $6,399.38. The contract has a firm fixed price pricing type and a final completion date of September 27, 2024. Amerisourcebergen has been awarded numerous federal contracts and Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The $7,442.58 firm fixed price delivery order is for the supply of GARDASIL 9 SYRINGE 0.5ML, a vaccine product. The contract has an ultimate completion date of September 10, 2024. Amerisourcebergen holds a Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued...
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The $12,648.84 firm fixed-price delivery order is for the supply of GARDASIL 9 SYRINGE 0.5ML, a vaccine product. The contract has an ultimate completion date of September 17, 2024 and did not utilize any set-aside. Amerisourcebergen, a major pharmaceutical distributor, has been awarded numerous federal contracts and...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of GARDASIL 9 SYRINGE 0.5ML, a pharmaceutical product, under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025. The delivery order has a ceiling value of $23,398.17 and a firm fixed price pricing type. The contract does not have a set-aside designation and is...
The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide GARDASIL 9 SYRINGE 0.5ML pharmaceutical products. The contract, valued at $20,560.75, has a completion date of January 31, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor and is not operating under any set-aside designation....
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The $10,074.64 firm-fixed-price contract is for the supply of 4565907464 GARDASIL 9 syringes, a vaccine product. The contract has an ultimate completion date of September 24, 2024. AmerisourceBergen, one of the largest pharmaceutical distributors in the United States, has been awarded numerous federal contracts and Indefinite Delivery Contracts (IDCs) by various...